Yves Beguin, MD, PhD
CHU-ULg
7
3
4
N/A
0
5
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (7)
Research Network
Collaboration Network
Research Areas & Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Frédéric Baron, MD, PhD
CHU-ULg
Shared therapeutic areas:
Worked with same sponsors:
Chantal Lechanteur, PhD
CHU-ULg
Shared therapeutic areas:
Worked with same sponsors:
Evelyne Willems, MD
CHU-ULg
Shared therapeutic areas:
Worked with same sponsors:
Etienne Baudoux, MD
CHU-ULg
Shared therapeutic areas:
Worked with same sponsors:
Lucien Noens, MD, PhD
UZG Gent
Shared therapeutic areas:
Worked with same sponsors:
Wilfried Schroyens, MD, PhD
UZA Antwerpen
Shared therapeutic areas:
Worked with same sponsors:
Chantal Doyen, MD, PhD
Cliiques Universitaire Mont-Godinne, Yvoir
Shared therapeutic areas:
Worked with same sponsors:
Pierre Zachée, MD, PhD
ZNA Antwerpen
Shared therapeutic areas:
Worked with same sponsors:
Rik Schots, MD, PhD
AZ VUB, Brussels
Shared therapeutic areas:
Worked with same sponsors:
Dominik Selleslag, MD, PhD
AZ Brugge
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (7)
Showing 7 of 7 trials
Mesenchymal Stem Cell Therapy for the Treatment of Severe or Refractory Inflammatory and/or Autoimmune Disorders
Mesenchymal Stem Cells After Renal or Liver Transplantation
MSC and HSC Coinfusion in Mismatched Minitransplants
Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function
Allogeneic HCT With HLA-matched Donors : a Phase II Randomized Study Comparing 2 Nonmyeloablative Conditionings
Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease
Erythropoietin (Epo) and Venofer Trial After Autologous Hematopoietic Stem Cell Transplantation (HSCT)
All 7 trials loaded